These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31060278)

  • 1. Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.
    Eveno T; Dirr L; El-Deeb IM; Guillon P; von Itzstein M
    Viruses; 2019 May; 11(5):. PubMed ID: 31060278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
    Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
    Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.
    Alymova IV; Taylor G; Takimoto T; Lin TH; Chand P; Babu YS; Li C; Xiong X; Portner A
    Antimicrob Agents Chemother; 2004 May; 48(5):1495-502. PubMed ID: 15105096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin-Neuraminidase Using Unsaturated 3- N-Substituted Sialic Acids as Probes.
    Pascolutti M; Dirr L; Guillon P; Van Den Bergh A; Ve T; Thomson RJ; von Itzstein M
    ACS Chem Biol; 2018 Jun; 13(6):1544-1550. PubMed ID: 29693380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.
    Alymova IV; Watanabe M; Boyd KL; Chand P; Babu YS; Portner A
    Antivir Ther; 2009; 14(7):891-8. PubMed ID: 19918093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed.
    Dirr L; El-Deeb IM; Guillon P; Carroux CJ; Chavas LM; von Itzstein M
    Angew Chem Int Ed Engl; 2015 Mar; 54(10):2936-40. PubMed ID: 25676091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design.
    Dirr L; El-Deeb IM; Chavas LMG; Guillon P; Itzstein MV
    Sci Rep; 2017 Jul; 7(1):4507. PubMed ID: 28674426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
    Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
    J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase inhibitors as antiviral agents.
    Alymova IV; Taylor G; Portner A
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):401-9. PubMed ID: 16535861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
    Alymova IV; Taylor G; Mishin VP; Watanabe M; Murti KG; Boyd K; Chand P; Babu YS; Portner A
    J Virol; 2008 Sep; 82(17):8400-10. PubMed ID: 18579600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
    Gorman WL; Pridgen C; Portner A
    Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
    Alymova IV; Portner A; Mishin VP; McCullers JA; Freiden P; Taylor GL
    Glycobiology; 2012 Feb; 22(2):174-80. PubMed ID: 21846691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.
    Watanabe M; Mishin VP; Brown SA; Russell CJ; Boyd K; Babu YS; Taylor G; Xiong X; Yan X; Portner A; Alymova IV
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3942-51. PubMed ID: 19564364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery.
    El-Deeb IM; Guillon P; Winger M; Eveno T; Haselhorst T; Dyason JC; von Itzstein M
    J Med Chem; 2014 Sep; 57(18):7613-23. PubMed ID: 25198831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of the inhibitory activity of 4-O-substituted sialic derivatives of human parainfluenza virus.
    Itoh Y; Sando A; Ikeda K; Suzuki T; Tokiwa H
    Glycoconj J; 2012 May; 29(4):231-7. PubMed ID: 22581169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by α-acylaminoamido groups at the C-4 position using isocyanide-based four-component coupling and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Nishino R; Hayakawa T; Takahashi T; Suzuki T; Sato M; Ikeda K
    Chem Pharm Bull (Tokyo); 2013; 61(1):69-74. PubMed ID: 23302587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors.
    Guillon P; Dirr L; El-Deeb IM; Winger M; Bailly B; Haselhorst T; Dyason JC; von Itzstein M
    Nat Commun; 2014 Oct; 5():5268. PubMed ID: 25327774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
    Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
    Gorman WL; Gill DS; Scroggs RA; Portner A
    Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.
    Alymova IV; Portner A; Takimoto T; Boyd KL; Babu YS; McCullers JA
    Antimicrob Agents Chemother; 2005 Jan; 49(1):398-405. PubMed ID: 15616320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.